Christopher Paul Simms

Insider Reports History

Location
New York, NY
Signature
/s/ Scott Bizily as Attorney-in-Fact for Christopher Paul Simms
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Paul Simms:

Company Role Class Num Shares Value Price $ Report Date Ownership
IVERIC bio, Inc. SVP, Chief Commercial Officer Common Stock 0 $39.45 11 Jul 2023 Direct
IVERIC bio, Inc. SVP, Chief Commercial Officer Restricted Stock Units 0 11 Jul 2023 Direct
IVERIC bio, Inc. SVP, Chief Commercial Officer Stock Option (Right to Buy) 0 $10.03 11 Jul 2023 Direct

Insider Reports Filed by Christopher Paul Simms

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FDMT 4D Molecular Therapeutics, Inc. 09 Dec 2025 0 $0 3 Chief Commercial Officer 19 Dec 2025, 16:12
ISEE IVERIC bio, Inc. 11 Jul 2023 7 $0 4 SVP, Chief Commercial Officer 13 Jul 2023, 13:58
ISEE IVERIC bio, Inc. 02 Jan 2023 3 -$47,502 4 SVP, Chief Commercial Officer 04 Jan 2023, 17:33
ISEE IVERIC bio, Inc. 20 Dec 2022 2 $0 4 SVP, Chief Commercial Officer 22 Dec 2022, 17:54
ISEE IVERIC bio, Inc. 02 Aug 2022 6 -$138,060 4 SVP, Chief Commercial Officer 04 Aug 2022, 16:09
ISEE IVERIC bio, Inc. 16 Dec 2021 2 $0 4 SVP, Chief Commercial Officer 20 Dec 2021, 15:34
ISEE IVERIC bio, Inc. 18 Nov 2021 1 +$50,025 4 SVP, Chief Commercial Officer 22 Nov 2021, 15:02
(ISEE) IVERIC bio, Inc. 02 Aug 2021 3 $0 4 Senior Vice President, CCO 04 Aug 2021, 19:53
ISEE IVERIC bio, Inc. 02 Aug 2021 0 $0 3 Senior Vice President, CCO 04 Aug 2021, 19:50